| Patient | Dorothea Lange |
|---|---|
| Date of birth | 1964-05-26 |
| Identifiers | MRN HR-ML045-SYN; SSN (made up) 000-45-9127 |
| Document date | 2026-08-17 |
| Author | Gwendolyn Ashford-Mensah, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-month review of post-polio syndrome, falls, bone health, and reflux. [S]
Ms. Lange is six months from the diagnosis of post-polio syndrome. She finished twelve weeks of physical therapy three months ago and does her home program four days a week. She has had no falls since the orthosis. She works in the field two days a week with a colleague carrying the tripod, rests the next day, and has less evening aching. She completed the eight-week omeprazole healing course and has stepped down to taking it only on days with symptoms, which is about four days a week; heartburn is controlled. She has had no difficulty swallowing, weight loss, or black stools. Dr. Haddad-Sorensen reviewed her in the neuromuscular clinic last week and found her strength unchanged. She has not had any procedure needing sedation since the endoscopy. [S]
| Element | Detail |
|---|---|
| Function | No falls; home exercise four days a week; two field days a week |
| Reflux | Healing course completed; omeprazole on about four days a week; symptoms controlled |
| Pain | 3 of 10 |
| Bone | Vitamin D taken daily; next zoledronic acid in April |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy better; weight up slightly |
| Musculoskeletal | Positive | Mild thigh aching after field days |
| Neurological | Negative | No new weakness |
| Respiratory | Negative | No breathlessness or morning headache |
| Gastrointestinal | Negative | Heartburn controlled; no difficulty swallowing |
| Psychiatric | Negative | Mood good; PHQ-9 2 |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for muscle aching, no more than 3000 mg a day | Two tablets up to every 8 hours as needed | Oral route | 2025-06-02 | active | S |
| Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth 30 to 60 minutes before breakfast, an eight-week trial for heartburn | One capsule once daily before breakfast | Oral route | 2026-02-09 to 2026-04-06 | completed | S |
| Cholecalciferol (vitamin D3) 1000 units oral tablet, two tablets (2000 units) by mouth once daily | Two tablets once daily | Oral route | 2026-02-25 | active | S |
| Calcium carbonate 500 mg chewable tablet, one or two tablets by mouth as needed for heartburn, no more than six tablets a day, while off omeprazole before the endoscopy | One or two tablets up to every 4 hours as needed | Oral route | 2026-04-20 to 2026-05-18 | completed | S |
| Zoledronic acid 5 mg in 100 mL intravenous infusion over at least 15 minutes once a year | One infusion once a year | Intravenous route | 2026-04-20 | active | S |
| Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth before breakfast for eight weeks to heal esophagitis, then the lowest dose that controls symptoms | One capsule once daily before breakfast | Oral route | 2026-05-18 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-08-17 | Body height | 152 | cm | S |
| 2026-08-17 | Body weight | 51 | kg | S |
| 2026-08-17 | Body mass index (BMI) [Ratio] | 22.1 | kg/m2 | S |
| 2026-08-17 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-08-17 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-08-17 | Heart rate | 72 | /min | S |
| 2026-08-17 | Respiratory rate | 14 | /min | S |
| 2026-08-17 | Body temperature | 36.7 | Cel | S |
| 2026-08-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-08-17 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S | ||
| 2026-08-17 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S |
Vital signs recorded on 2026-08-17; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well |
| Neurological | Strength (MRC) unchanged from the baseline six months ago: left quadriceps 4/5, left hip abductors 4/5, right quadriceps 3+/5, right ankle dorsiflexion 2/5, deltoids 4+/5 |
| Gait | Steady with the orthosis and cane; Timed Up and Go 11.2 seconds |
| Skin | No pressure marks from the orthosis |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| New fatigue and slowly increasing weakness for about 18 months, in the left leg and both arms as well as the right leg weakened by polio at seven, with aching muscle pain after work and cold intolerance of the right leg; cause to be established | resolved | confirmed | M62.81 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis of post-polio syndrome at the second visit; the paralytic polio of 1902 is documented (D). |
| Post-polio syndrome (modified March of Dimes criteria met): new weakness of the left quadriceps and both shoulder girdles and increased weakness of the right leg, with fatigue, muscle pain, and cold intolerance, more than 50 years after paralytic polio with partial recovery and decades of stable function; nerve conduction normal; EMG chronic reinnervation in both legs and the right deltoid; other causes excluded | active | confirmed | G14 | S — Synthetic modern diagnosis; the childhood polio is documented (D), and her biographer's account of post-polio symptoms later in life is a retrospective interpretation (R). No neurological finding from her lifetime is used. |
| Heartburn and regurgitation after meals and at night for three months, three to four times a week; no difficulty swallowing, weight loss, vomiting, bleeding, or anemia | resolved | confirmed | R12 | S — Synthetic presenting symptom at the index visit, superseded by the endoscopic diagnosis at the fourth visit. |
| Gastroesophageal reflux disease with Los Angeles grade B erosive esophagitis on upper endoscopy off proton pump inhibitor; no Barrett's esophagus | active | confirmed | K21.00 | S — Synthetic endoscopic diagnosis; it does not echo or foreshadow her later documented illness. |
| Small (2 cm) sliding hiatal hernia on upper endoscopy | active | confirmed | K44.9 | S — Synthetic endoscopic finding. |
| Osteoporosis, worst at the right hip on the polio-weakened side (right femoral neck T-score -2.7; left -1.6; lumbar spine -1.8), with vitamin D insufficiency; no vertebral fracture on assessment; 10-year FRAX risk about 16 percent major osteoporotic and 4.5 percent hip | active | confirmed | M81.8 | S — Synthetic bone density result; disuse of a polio-affected limb lowers bone density on that side. |
| Two falls in the past year without injury, from catching the right foot | active | confirmed | Z91.81 | S — Synthetic fall history at presentation. |
| Surgery for severe stomach ulcers in her early fifties; no ulcer symptoms since; avoids nonsteroidal anti-inflammatory drugs | active | confirmed | Z87.11 | S — Synthetic modern history entry linked to the documented ulcers and surgery of the late 1940s (D); the type of operation is not known. |
| Acute-phase reaction two days after the first zoledronic acid infusion: fever to 38.1 °C, muscle and joint aching, and headache, without signs of infection; calcium normal; resolved in three days with acetaminophen and fluids | resolved | confirmed | T50.995A | S — Synthetic expected adverse effect of a first intravenous bisphosphonate dose. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Manual muscle testing and Timed Up and Go | Every visit | Completed today | Strength stable over six months; TUG 11.2 seconds |
| Survey | Pain score | Every visit | Completed today | Pain 3 of 10 |
| Survey | Depression screen (PHQ-9) | Periodically | Completed today | PHQ-9 2 |
| Imaging | Spirometry | Yearly or with symptoms | Up to date | Normal six months ago; due at one year |
| Examination | Sleep and breathing symptoms | Every visit | Completed today | Sleep refreshing; no morning headache |
| Examination | Swallowing screen | Every visit | Completed today | No difficulty swallowing |
| Examination | Orthosis fit and skin check | Every visit | Completed today | Good fit |
| Self-management | Home exercise and pacing | Every visit | Completed today | Four days a week of home exercise; two field days with rest days |
| Examination | Fall review | Every visit | Completed today | No falls in six months |
| Medication safety | Proton pump inhibitor at the lowest effective dose | At each review | Completed today | Stepped down to symptom days only |
| Medication safety | Zoledronic acid: next dose checks | Before each infusion | Due | Calcium, vitamin D, creatinine, and dental status before the April infusion |
| Laboratory | 25-hydroxyvitamin D | After repletion, then yearly | Up to date | 34 ng/mL four months ago on 2000 units daily |
| Imaging | Bone density (DXA) | Every 2 years on treatment | Up to date | Next two years after the first scan |
| Laboratory | 24-hour urine calcium | At diagnosis | Due | Collection planned in the week before the yearly review |
| Examination | Height measurement | Yearly | Due | At the yearly review |
Goal progress:
Guideline basis: EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol 2006;13(8):795-801 (2006); ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol 2022;117(1):27-56 (2022); World guidelines for falls prevention and management for older adults: a global initiative. Age Ageing 2022;51(9):afac205 (2022); CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026)
Follow-up: Adult preventive visit in six weeks. Post-polio syndrome and bone review at one year with spirometry, vitamin D, calcium, and creatinine, then the second zoledronic acid infusion. Next scheduled visit 2026-09-28: adult preventive visit. [S]